Concepedia

Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

Deepa Magge, Mazen S. Zenati, Frances Austin, Arun Mavanur, Magesh Sathaiah, Lekshmi Ramalingam, Heather Jones, Amer H. Zureikat, Matthew P. Holtzman, Steven A. Ahrendt,

Annals of Surgical Oncology · 2013 · 110 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Classification of Surgical Complications

Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien · Annals of Surgery · 2004 · 30.9K citations · Full text

, , +13

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2003 · 3.1K citations

, , +13

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel et al. · New England Journal of Medicine · 2006 · 2.6K citations · Full text

, , +14

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

Tristan D. Yan, Marcello Deraco, Dario Baratti et al. · Journal of Clinical Oncology · 2009 · 685 citations · Full text

, , +13

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

Jan P. van Meerbeeck, Rabab Gaafar, Christian Manegold et al. · Journal of Clinical Oncology · 2005 · 621 citations · Full text

, , +14